Erin Wright
Stock Analyst at Morgan Stanley
(4.54)
# 253
Out of 5,056 analysts
243
Total ratings
64.94%
Success rate
14.62%
Average return
Main Sectors:
Stocks Rated by Erin Wright
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZTS Zoetis | Maintains: Overweight | $211 → $175 | $118.14 | +48.13% | 8 | Nov 10, 2025 | |
| MCK McKesson | Maintains: Overweight | $857 → $916 | $860.75 | +6.42% | 10 | Nov 6, 2025 | |
| HSIC Henry Schein | Maintains: Underweight | $55 → $58 | $71.20 | -18.54% | 5 | Nov 5, 2025 | |
| IDXX IDEXX Laboratories | Maintains: Overweight | $765 → $805 | $670.21 | +20.11% | 19 | Nov 4, 2025 | |
| ALGN Align Technology | Maintains: Equal-Weight | $142 → $154 | $132.28 | +16.42% | 25 | Oct 30, 2025 | |
| OPCH Option Care Health | Initiates: Overweight | $35 | $28.28 | +23.76% | 1 | Oct 17, 2025 | |
| MOH Molina Healthcare | Maintains: Equal-Weight | $163 → $204 | $141.19 | +44.49% | 3 | Oct 14, 2025 | |
| ELV Elevance Health | Maintains: Equal-Weight | $316 → $359 | $324.53 | +10.62% | 4 | Oct 14, 2025 | |
| CVS CVS Health | Maintains: Overweight | $82 → $89 | $77.94 | +14.19% | 6 | Oct 14, 2025 | |
| BTSG BrightSpring Health Services | Maintains: Overweight | $25 → $32 | $31.55 | +1.43% | 4 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $128 → $140 | $138.41 | +1.15% | 2 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $17 | $19.13 | -11.13% | 9 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $290 → $277 | $234.10 | +18.33% | 4 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $313 → $330 | $361.64 | -8.75% | 1 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $181 → $190 | $206.97 | -8.20% | 12 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $21 → $26 | $43.38 | -40.06% | 23 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $379 → $390 | $272.61 | +43.06% | 5 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $3.5 → $3.2 | $1.86 | +72.04% | 12 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $14 → $13 | $21.39 | -39.22% | 11 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $23 | $10.26 | +124.17% | 12 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $145 → $172 | $185.32 | -7.19% | 5 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $587 | $313.58 | +87.19% | 3 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Overweight | $300 | $259.81 | +15.47% | 4 | Aug 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $39 → $42 | $11.14 | +277.02% | 5 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $282 → $288 | $225.51 | +27.71% | 6 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $342 → $352 | $162.53 | +116.58% | 4 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $42 → $44 | $3.62 | +1,115.47% | 2 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $178 → $181 | $590.18 | -69.33% | 8 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $53.50 | -68.22% | 6 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $121 | $34.52 | +250.52% | 7 | Jan 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $556 → $580 | $576.03 | +0.69% | 4 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $35 | $8.13 | +330.50% | 1 | Jan 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $181 → $205 | $161.02 | +27.31% | 2 | Jul 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $11 | $29.10 | -62.20% | 6 | May 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $175 → $157 | $217.28 | -27.74% | 1 | Apr 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $42 → $38 | $28.20 | +34.75% | 1 | May 9, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $31 → $17 | $2.89 | +488.24% | 1 | Nov 20, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $300 → $308 | $474.72 | -35.12% | 1 | Oct 25, 2017 |
Zoetis
Nov 10, 2025
Maintains: Overweight
Price Target: $211 → $175
Current: $118.14
Upside: +48.13%
McKesson
Nov 6, 2025
Maintains: Overweight
Price Target: $857 → $916
Current: $860.75
Upside: +6.42%
Henry Schein
Nov 5, 2025
Maintains: Underweight
Price Target: $55 → $58
Current: $71.20
Upside: -18.54%
IDEXX Laboratories
Nov 4, 2025
Maintains: Overweight
Price Target: $765 → $805
Current: $670.21
Upside: +20.11%
Align Technology
Oct 30, 2025
Maintains: Equal-Weight
Price Target: $142 → $154
Current: $132.28
Upside: +16.42%
Option Care Health
Oct 17, 2025
Initiates: Overweight
Price Target: $35
Current: $28.28
Upside: +23.76%
Molina Healthcare
Oct 14, 2025
Maintains: Equal-Weight
Price Target: $163 → $204
Current: $141.19
Upside: +44.49%
Elevance Health
Oct 14, 2025
Maintains: Equal-Weight
Price Target: $316 → $359
Current: $324.53
Upside: +10.62%
CVS Health
Oct 14, 2025
Maintains: Overweight
Price Target: $82 → $89
Current: $77.94
Upside: +14.19%
BrightSpring Health Services
Oct 14, 2025
Maintains: Overweight
Price Target: $25 → $32
Current: $31.55
Upside: +1.43%
Oct 3, 2025
Maintains: Equal-Weight
Price Target: $128 → $140
Current: $138.41
Upside: +1.15%
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $19.13
Upside: -11.13%
Jul 31, 2025
Maintains: Equal-Weight
Price Target: $290 → $277
Current: $234.10
Upside: +18.33%
Jul 16, 2025
Maintains: Equal-Weight
Price Target: $313 → $330
Current: $361.64
Upside: -8.75%
Jul 16, 2025
Maintains: Overweight
Price Target: $181 → $190
Current: $206.97
Upside: -8.20%
Jun 25, 2025
Maintains: Equal-Weight
Price Target: $21 → $26
Current: $43.38
Upside: -40.06%
May 5, 2025
Maintains: Overweight
Price Target: $379 → $390
Current: $272.61
Upside: +43.06%
Apr 17, 2025
Maintains: Underweight
Price Target: $3.5 → $3.2
Current: $1.86
Upside: +72.04%
Feb 26, 2025
Maintains: Equal-Weight
Price Target: $14 → $13
Current: $21.39
Upside: -39.22%
Dec 17, 2024
Maintains: Overweight
Price Target: $30 → $23
Current: $10.26
Upside: +124.17%
Dec 17, 2024
Upgrades: Overweight
Price Target: $145 → $172
Current: $185.32
Upside: -7.19%
Jul 14, 2023
Reiterates: Overweight
Price Target: $587
Current: $313.58
Upside: +87.19%
Aug 22, 2022
Assumes: Overweight
Price Target: $300
Current: $259.81
Upside: +15.47%
Jul 30, 2021
Maintains: Outperform
Price Target: $39 → $42
Current: $11.14
Upside: +277.02%
Jun 18, 2021
Maintains: Outperform
Price Target: $282 → $288
Current: $225.51
Upside: +27.71%
May 28, 2021
Maintains: Neutral
Price Target: $342 → $352
Current: $162.53
Upside: +116.58%
May 11, 2021
Maintains: Outperform
Price Target: $42 → $44
Current: $3.62
Upside: +1,115.47%
Mar 17, 2021
Maintains: Outperform
Price Target: $178 → $181
Current: $590.18
Upside: -69.33%
Feb 26, 2021
Maintains: Neutral
Price Target: $14 → $17
Current: $53.50
Upside: -68.22%
Jan 13, 2021
Maintains: Outperform
Price Target: $104 → $121
Current: $34.52
Upside: +250.52%
Jan 12, 2021
Maintains: Outperform
Price Target: $556 → $580
Current: $576.03
Upside: +0.69%
Jan 5, 2021
Initiates: Neutral
Price Target: $35
Current: $8.13
Upside: +330.50%
Jul 23, 2020
Maintains: Outperform
Price Target: $181 → $205
Current: $161.02
Upside: +27.31%
May 5, 2020
Maintains: Neutral
Price Target: $12 → $11
Current: $29.10
Upside: -62.20%
Apr 2, 2020
Maintains: Outperform
Price Target: $175 → $157
Current: $217.28
Upside: -27.74%
May 9, 2018
Maintains: Outperform
Price Target: $42 → $38
Current: $28.20
Upside: +34.75%
Nov 20, 2017
Maintains: Underperform
Price Target: $31 → $17
Current: $2.89
Upside: +488.24%
Oct 25, 2017
Maintains: Neutral
Price Target: $300 → $308
Current: $474.72
Upside: -35.12%